Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues from Young Rats

被引:10
作者
Pullen, Candice [1 ]
Coulson, Fiona R. [1 ]
Fenning, Andrew [1 ]
机构
[1] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia
关键词
D O I
10.1155/2014/720386
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanisms by which resveratrol and nebivolol induce vasodilation are not clearly understood. It has been postulated that both agents stimulate the production of nitric oxide; however, this remains to be conclusively established. The major aim of this study was to examine the vasodilatory and antiarrhythmic effects of both resveratrol and nebivolol and to provide further insight into possible mechanisms of action. Cardiac and vascular tissues were isolated from healthy male rodents. Results indicate that resveratrol and nebivolol decrease the action potential duration and induce mild vasorelaxation in aortic and mesenteric segments. Relaxation induced by resveratrol was prevented by the addition of verapamil, N omega-nitro-L-arginine-methyl ester, and 4-aminopyridine. This suggests that nebivolol and resveratrol act as putative antiarrhythmic and vasodilatory agents in vitro through possible indirect nitric oxide mechanisms.
引用
收藏
页数:8
相关论文
共 36 条
  • [1] The negative inotropic effect of esmolol on isolated cardiac muscle
    Arlock, P
    Wohlfart, B
    Sjöberg, T
    Steen, S
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2005, 39 (04) : 250 - 254
  • [2] Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats
    Bhatt, Siddhartha R.
    Lokhandwala, Mustafa F.
    Banday, Anees Ahmad
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 667 (1-3) : 258 - 264
  • [3] Nebivolol:: A third-generation β-blocker that augments vascular nitric oxide release endothelial β2-adrenergic receptor-mediated nitric oxide production
    Broeders, MAW
    Doevendans, PA
    Bekkers, BCAM
    Bronsaer, R
    van Gorsel, E
    Heemskerk, JWM
    Egbrink, MGAO
    van Breda, E
    Reneman, RS
    van der Zee, R
    [J]. CIRCULATION, 2000, 102 (06) : 677 - 684
  • [4] Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
    Chan, Vincent
    Fenning, Andrew
    Iyer, Abishek
    Hoey, Andrew
    Brown, Lindsay
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 429 - 436
  • [5] Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
    Chang, Chih-Chun
    Chang, Chieh-Yu
    Wu, Yang-Tzu
    Huang, Jiung-Pang
    Yen, Tzung-Hai
    Hung, Li-Man
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2011, 18
  • [6] In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant
    Chen, Wen-Pin
    Su, Ming-Jai
    Hung, Li-Man
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 554 (2-3) : 196 - 204
  • [7] Chlopicki S, 2002, J PHYSIOL PHARMACOL, V53, P615
  • [8] COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067
  • [9] L-arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats
    Fenning, A
    Harrison, G
    Rose'meyer, R
    Hoey, A
    Brown, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (04): : H1408 - H1416
  • [10] Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy
    Galetta, F
    Franzoni, F
    Magagna, A
    Femia, FR
    Pentimone, F
    Santoro, G
    Carpi, A
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (1-2) : 15 - 19